Ochiai and colleagues performed a systematic review and meta-analysis of three retrospective non-randomized comparative studies to determine the impact of EGFR sensitizing mutations in locally advanced NSCLC treated with concurrent chemo-radiotherapy on patterns of recurrence, recurrence-free and overall survival [17]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.